Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001209191-22-039905

Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BAKER BROS. ADVISORS LP Director 2022-06-29 Grant or award +10,000 108,980 I: show line 1 in the form
BAKER BROS. ADVISORS LP Director 2022-06-29 Grant or award +10,000 2,710,597 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BAKER BROS. ADVISORS LP Director 2022-06-29 Grant or award · Non-Qualified Share Option (right to buy) +60,000 60,000 I: show line 3 in the form
Loading xslF345X03/doc4.xml…